Abeona Therapeutics Inc logo

Abeona Therapeutics Inc

NAS:ABEO (USA)  
$ 4.31 -0.14 (-3.15%) 10:08 PM EST
At Loss
Market Cap:
$ 177.51M
Enterprise V:
$ 144.10M
Volume:
602.36K
Avg Vol (2M):
819.22K
Also Trade In:
Volume:
602.36K
At Loss
Avg Vol (2M):
819.22K

Business Description

Description
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
Name Current Vs Industry Vs History
Cash-To-Debt 2.69
Equity-to-Asset -0.12
Debt-to-Equity -2.61
Debt-to-EBITDA -0.32
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -15.7
Distress
Grey
Safe
Beneish M-Score -0.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 42.19
9-Day RSI 42.14
14-Day RSI 40.67
6-1 Month Momentum % 81.53
12-1 Month Momentum % 144.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.61
Quick Ratio 5.61
Cash Ratio 5.24
Days Sales Outstanding 365
Days Payable 643.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -90.4
Shareholder Yield % -25.05

Financials (Next Earnings Date:2024-08-08 Est.)

ABEO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ABEO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Abeona Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.5
EPS (TTM) ($) -3.2
Beta 1.41
Volatility % 101.31
14-Day RSI 40.67
14-Day ATR ($) 0.505235
20-Day SMA ($) 4.157
12-1 Month Momentum % 144.19
52-Week Range ($) 2.83 - 9.01
Shares Outstanding (Mil) 41.19

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abeona Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Abeona Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Abeona Therapeutics Inc Frequently Asked Questions

What is Abeona Therapeutics Inc(ABEO)'s stock price today?
The current price of ABEO is $4.31. The 52 week high of ABEO is $9.01 and 52 week low is $2.83.
When is next earnings date of Abeona Therapeutics Inc(ABEO)?
The next earnings date of Abeona Therapeutics Inc(ABEO) is 2024-08-08 Est..
Does Abeona Therapeutics Inc(ABEO) pay dividends? If so, how much?
Abeona Therapeutics Inc(ABEO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1